Fibrinogen, blood viscosity, and cerebral ischemia.
This study examines the effect of fibrinogen and consequent blood viscosity reduction on cerebral blood flow and cellular injury following severe cerebral ischemia for 30 minutes in 78 Wistar rats. In half of these rats 10 to 15 cc's of blood was removed and replaced with a mixture of 5% albumin and autologous red blood cells maintaining a constant hematocrit but resulting in a 30% decrease in fibrinogen and corresponding reduction in viscosity. Fibrinogen reduction in a slight increase in baseline CBF and the elimination of post-ischemic hyperemia at 24 hours. Both study and control animals showed a similar decrease in CBF at 30 minutes and 2 hours. There was no significant difference in the severity of ischemic cellular change between the fibrinogen reduction group and controls, although there was a significant inverse relationship between the amount of viscosity change and severity of cellular injury within the treatment group. Fibrinogen reduction alone cannot significantly ameliorate ischemic injury in this model. Viscosity reduction therapy should include reduction of hematocrit and alteration of red cell deformability.
D000818:Animals; D001809:Blood Viscosity; D001921:Brain / Q000098:blood supply / Q000473:pathology; D002545:Brain Ischemia / Q000097:blood* / Q000473:pathology / Q000503:physiopathology; D002560:Cerebrovascular Circulation; D005340:Fibrinogen / Q000378:metabolism* / Q000502:physiology; D008297:Male; D010477:Perfusion; D010951:Plasma Exchange; D051381:Rats; D011919:Rats, Inbred Strains; D012212:Rheology; D013997:Time Factors; D014655:Vascular Resistance
D005340:Fibrinogen